ISRG - Intuitive Surgical Inc Stock Price, Fair Value and News

372.82USD-1.35 (-0.36%)Market Closed

Market Summary

USD372.82-1.35

Market Closed

-0.36%

ISRG Alerts

2 major insider sales recently.

ISRG Stock Price

View Fullscreen

ISRG RSI Chart

ISRG Valuation

Market Cap

131.4B

Price/Earnings (Trailing)

73.06

Price/Sales (Trailing)

18.44

EV/EBITDA

65.65

Price/Free Cashflow

72.42

ISRG Price/Sales (Trailing)

ISRG Profitability

Operating Margin

85.57%

EBT Margin

27.50%

Return on Equity

13.51%

Return on Assets

11.64%

Free Cashflow Yield

1.38%

ISRG Fundamentals

ISRG Revenue

Revenue (TTM)

7.1B

Rev. Growth (Yr)

16.51%

Rev. Growth (Qtr)

10.59%

ISRG Earnings

Earnings (TTM)

1.8B

Earnings Growth (Yr)

86.58%

Earnings Growth (Qtr)

45.83%

Breaking Down ISRG Revenue

Last 7 days

-5.0%

Last 30 days

-4.5%

Last 90 days

-0.5%

Trailing 12 Months

24.9%

How does ISRG drawdown profile look like?

ISRG Financial Health

Current Ratio

4.76

ISRG Investor Care

Shares Dilution (1Y)

0.55%

Diluted EPS (TTM)

5.03

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	6.4B	6.7B	6.9B	7.1B
2022	5.9B	6.0B	6.1B	6.2B
2021	4.6B	5.2B	5.5B	5.7B
2020	4.6B	4.4B	4.3B	4.4B
2019	3.9B	4.0B	4.2B	4.5B
2018	3.3B	3.5B	3.6B	3.7B
2017	2.8B	2.9B	3.0B	3.1B
2016	2.4B	2.5B	2.6B	2.7B
2015	2.2B	2.3B	2.3B	2.4B
2014	2.1B	2.1B	2.1B	2.1B
2013	2.3B	2.3B	2.3B	2.3B
2012	1.9B	2.0B	2.1B	2.2B
2011	1.5B	1.5B	1.6B	1.8B
2010	1.2B	1.3B	1.3B	1.4B
2009	875.1M	916.5M	960.6M	1.1B
2008	0	692.2M	783.5M	874.9M
2007	0	0	0	600.8M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Intuitive Surgical Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 15, 2024	widman fredrik	sold	-1,758,620	397	-4,429	vp corporate controller
Mar 15, 2024	widman fredrik	acquired	36,247	59.2278	612	vp corporate controller
Mar 11, 2024	brosius mark	sold	-76,471	390	-196	svp & chief mfg and supply cha
Mar 11, 2024	desantis robert	sold	-128,363	390	-329	evp & chief strategy & corp op
Mar 11, 2024	desantis robert	acquired	79,955	243	329	evp & chief strategy & corp op
Mar 08, 2024	desantis robert	acquired	4,383,440	297	14,728	evp & chief strategy & corp op
Mar 08, 2024	brosius mark	sold	-76,835	392	-196	svp & chief mfg and supply cha
Mar 08, 2024	desantis robert	sold	-7,992,510	393	-20,296	evp & chief strategy & corp op
Mar 07, 2024	brosius mark	sold	-77,086	393	-196	svp & chief mfg and supply cha
Mar 06, 2024	brosius mark	sold	-75,805	386	-196	svp & chief mfg and supply cha

Which funds bought or sold ISRG recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 17, 2024	Kathleen S. Wright Associates Inc.	unchanged	-	3,703	23,945	0.01%
Apr 17, 2024	BURNS J W & CO INC/NY	added	4.71	563,748	2,924,930	0.41%
Apr 17, 2024	Portside Wealth Group, LLC	added	10.17	83,497	358,782	0.07%
Apr 17, 2024	First Bank & Trust	reduced	-1.96	436,249	3,167,180	0.66%
Apr 17, 2024	FOUNDERS FINANCIAL SECURITIES LLC	reduced	-22.17	-66,500	771,840	0.08%
Apr 17, 2024	Hennion & Walsh Asset Management, Inc.	added	8.61	688,720	3,106,920	0.17%
Apr 17, 2024	NEW MEXICO EDUCATIONAL RETIREMENT BOARD	added	14.25	134,000	6,288,000	0.23%
Apr 17, 2024	D.B. Root & Company, LLC	added	2.31	70,662	406,673	0.14%
Apr 17, 2024	Bremer Bank National Association	new	-	256,215	256,215	0.05%
Apr 17, 2024	CLIFFORD SWAN INVESTMENT COUNSEL LLC	unchanged	-	64,817	419,045	0.02%

Are Funds Buying or Selling ISRG?

Are funds buying ISRG calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ISRG

No. of Funds

ISRG Alerts

2 major insider sales recently.

Unveiling Intuitive Surgical Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	price t rowe associates inc /md/	4.8%	16,990,447	SC 13G/A
Feb 13, 2024	vanguard group inc	8.63%	30,375,212	SC 13G/A
Jan 25, 2024	blackrock inc.	8.4%	29,575,972	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	5.9%	20,823,995	SC 13G/A
Feb 09, 2023	vanguard group inc	8.33%	29,425,186	SC 13G/A
Feb 03, 2023	blackrock inc.	8.0%	28,447,145	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	6.9%	24,756,021	SC 13G/A
Feb 07, 2022	blackrock inc.	7.4%	26,538,660	SC 13G/A
Feb 16, 2021	price t rowe associates inc /md/	8.1%	9,599,898	SC 13G/A
Feb 10, 2021	vanguard group inc	7.76%	9,127,891	SC 13G/A

Recent SEC filings of Intuitive Surgical Inc

View All Filings

Date Filed	Form Type	Document
Apr 18, 2024	8-K	Current Report
Mar 18, 2024	4	Insider Trading
Mar 15, 2024	144	Notice of Insider Sale Intent
Mar 14, 2024	8-K	Current Report
Mar 11, 2024	144	Notice of Insider Sale Intent
Mar 11, 2024	144	Notice of Insider Sale Intent
Mar 11, 2024	4	Insider Trading
Mar 11, 2024	4	Insider Trading
Mar 08, 2024	144	Notice of Insider Sale Intent
Mar 08, 2024	DEFA14A	DEFA14A

Peers (Alternatives to Intuitive Surgical Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	182.6B	40.1B	-6.98%	-6.26%	31.91	4.55	-8.12%	-17.45%
BDX	67.4B	19.5B	-2.95%	-9.93%	53.63	3.46	4.02%	-22.04%
ALGN	22.6B	3.9B	-4.96%	-15.40%	50.88	5.86	3.42%	23.09%
BAX	20.1B	14.8B	-5.44%	-9.06%	7.58	1.36	2.12%	209.17%
MID-CAP
ATR	9.2B	3.5B	-0.25%	17.23%	32.29	2.63	4.97%	18.89%
HSIC	9.0B	12.3B	-5.97%	-15.68%	21.61	0.73	-2.44%	-22.68%
BIO	8.2B	2.7B	-16.50%	-42.23%	-12.88	3.07	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.09%	-25.03%	-46.91	1.59	1.10%	85.84%
AXNX	3.4B	366.4M	-2.40%	13.34%	-563.48	9.33	33.86%	89.83%
PDCO	2.3B	6.6B	-5.10%	-3.56%	11.8	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.2B	3.2B	-10.67%	-21.18%	-1.84	0.39	7.73%	-1066.14%
ANIK	378.4M	166.7M	0.43%	-6.80%	-4.58	2.27	6.67%	-456.34%
ANGO	245.1M	324.0M	10.27%	-31.54%	-1.27	0.76	-3.19%	-337.41%
APYX	47.5M	52.3M	-23.89%	-53.56%	-2.54	0.91	17.61%	19.28%
AEMD	3.7M	3.7M	-12.80%	240.48%	-0.31	1	5.77%	8.23%

Intuitive Surgical Inc News

Latest updates

Intuitive Surgical Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	10.6%	1,928	1,744	1,756	1,696	1,655	1,557	1,522	1,488	1,551	1,403	1,464	1,292	1,329	1,078	852	1,100	1,278	1,128	1,099	974	1,047
Gross Profit	9.4%	1,277	1,167	1,172	1,113	1,111	1,052	1,023	1,010	1,061	971	1,024	903	896	724	503	738	896	786	759	670	736
Operating Expenses	17.9%	827	701	709	725	738	653	626	602	610	529	513	486	480	454	422	455	498	420	400	417	404
S&GA Expenses	25.5%	567	452	464	481	494	436	418	391	427	363	350	326	330	299	279	308	342	284	279	273	284
R&D Expenses	4.3%	260	249	244	245	244	217	207	211	183	166	162	160	150	155	143	147	157	136	121	144	120
EBITDA Margin	2.5%	0.27*	0.27*	0.27*	0.26*	0.27*	0.28*	0.30*	0.32*	0.34*	0.35*	0.35*	0.31*	0.29*	0.29*	-	-	-	-	-	-	-
Income Taxes	-192.8%	-94.80	102	73.00	61.00	58.00	78.00	93.00	33.00	72.00	74.00	3.00	14.00	73.00	38.00	37.00	-8.10	69.00	0.00	75.00	-24.30	68.00
Earnings Before Taxes	-1.2%	516	522	499	422	395	403	407	402	454	461	526	449	437	355	107	308	432	399	392	280	359
EBT Margin	2.5%	0.27*	0.27*	0.26*	0.25*	0.26*	0.27*	0.29*	0.31*	0.33*	0.34*	0.34*	0.30*	0.28*	0.28*	-	-	-	-	-	-	-
Net Income	45.8%	606	416	421	355	325	324	308	366	381	381	517	426	365	314	68.00	314	358	397	318	307	293
Net Income Margin	14.0%	0.25*	0.22*	0.21*	0.20*	0.21*	0.23*	0.24*	0.28*	0.30*	0.31*	0.31*	0.26*	0.24*	0.24*	-	-	-	-	-	-	-
Free Cashflow	-58.4%	228	548	666	371	438	383	447	223	568	501	543	478	628	275	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	5.0%	15,442	14,713	13,903	13,053	12,974	13,261	13,705	13,678	13,555	12,935	12,297	11,540	11,169	10,618	10,104	9,891	9,733	9,131	8,532	8,235	7,847
Current Assets	-11.4%	7,888	8,903	8,032	6,877	6,253	6,293	6,293	5,803	5,845	5,728	6,017	6,066	6,626	6,300	5,899	4,692	4,663	4,317	4,072	4,025	4,333
Cash Equivalents	-23.7%	2,750	3,602	3,435	2,143	1,581	1,554	1,551	1,118	1,306	1,362	1,631	1,418	1,639	1,386	2,052	1,239	1,183	985	805	891	909
Inventory	6.4%	1,221	1,148	1,005	947	893	837	724	653	587	585	570	577	602	663	646	620	596	580	513	468	409
Net PPE	15.0%	3,538	3,077	2,831	2,580	2,374	2,244	2,109	1,968	1,876	1,738	1,651	1,593	1,577	1,510	1,450	1,369	1,273	1,137	1,032	935	812
Goodwill	0.2%	349	348	349	349	349	348	349	343	344	344	344	345	337	336	337	335	307	305	245	248	6.00
Liabilities	-2.2%	2,044	2,089	1,944	1,759	1,861	1,687	1,623	1,522	1,604	1,475	1,418	1,350	1,410	1,331	1,337	1,361	1,449	1,354	1,252	1,195	1,159
Current Liabilities	-1.1%	1,659	1,676	1,538	1,307	1,422	1,233	1,175	1,112	1,150	1,027	1,005	905	965	895	925	946	1,030	931	808	740	821
Shareholder's Equity	6.1%	13,308	12,539	11,960	11,294	11,042	11,574	12,082	12,157	11,952	11,460	10,880	10,190	9,759	9,287	8,766	8,531	8,285	7,777	7,280	7,040	6,688
Retained Earnings	12.7%	4,743	4,209	3,808	3,397	3,500	4,018	4,683	4,858	4,761	4,390	4,023	3,515	3,261	2,937	2,633	2,571	2,495	2,143	1,819	1,696	1,522
Additional Paid-In Capital	2.3%	8,576	8,386	8,151	7,928	7,704	7,685	7,484	7,355	7,164	7,015	6,804	6,627	6,445	6,304	6,085	5,927	5,757	5,601	5,430	5,329	5,170
Accumulated Depreciation	-	1,562	-	-	-	1,238	-	-	-	969	-	-	-	758	-	-	-	563	-	-	-	436
Shares Outstanding	0.1%	352	352	351	350	350	357	358	358	356	357	356	354	351	351	-	-	-	-	-	-	-
Minority Interest	6.2%	90.00	85.00	81.00	77.00	71.00	59.00	59.00	55.00	50.00	49.00	42.00	37.00	28.00	29.00	26.00	24.00	21.00	16.00	14.00	16.00	9.00
Float	-	-	-	119,600	-	-	-	71,400	-	-	-	108,700	-	-	-	66,400	-	-	-	59,900	-	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-58.4%	228	548	666	371	438	383	447	223	568	501	543	478	628	275	230	353	553	396	316	333	338
Share Based Compensation	-3.7%	150	156	147	140	128	138	127	121	118	120	108	103	103	106	96.00	91.00	89.00	89.00	82.00	76.00	70.00
Cashflow From Investing	-133.8%	-1,044	-446	558	573	575	545	466	-214	-641	-838	-384	-597	-334	-1,025	537	-117	-406	-216	-222	-308	-486
Cashflow From Financing	-151.0%	-31.50	62.00	63.00	-381	-963	-926	-482	-199	19.00	68.00	58.00	-102	-39.80	85.00	48.00	-178	51.00	1.00	-178	-41.80	34.00
Buy Backs	-	66.00	-	-	350	1,001	1,000	500	107	-	-	-	-	34.00	-	-	100	-	70.00	200	-	-

ISRG Income Statement

2023-12-31

Consolidated Statements Of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue:
Total revenue	$ 7,124.1	$ 6,222.2	$ 5,710.1
Cost of revenue:
Total cost of revenue	2,394.6	2,026.2	1,751.6
Gross profit	4,729.5	4,196.0	3,958.5
Operating expenses:
Selling, general and administrative	1,963.9	1,739.9	1,466.5
Research and development	998.8	879.0	671.0
Total operating expenses	2,962.7	2,618.9	2,137.5
Income from operations	1,766.8	1,577.1	1,821.0
Interest and other income, net	192.1	29.7	69.3
Income before taxes	1,958.9	1,606.8	1,890.3
Income tax expense	141.6	262.4	162.2
Net income	1,817.3	1,344.4	1,728.1
Less: net income attributable to noncontrolling interest in joint venture	19.3	22.1	23.5
Net income attributable to Intuitive Surgical, Inc.	$ 1,798.0	$ 1,322.3	$ 1,704.6
Net income per share attributable to Intuitive Surgical, Inc.:
Basic (usd per share)	$ 5.12	$ 3.72	$ 4.79
Diluted (usd per share)	$ 5.03	$ 3.65	$ 4.66
Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:
Basic (shares)	351.2	355.7	356.1
Diluted (shares)	357.4	362.0	365.8
Joint venture
Operating expenses:
Less: net income attributable to noncontrolling interest in joint venture	$ 19.3	$ 22.1	$ 23.5
Product
Revenue:
Total revenue	5,956.3	5,198.0	4,793.9
Cost of revenue:
Total cost of revenue	2,041.8	1,700.3	1,464.1
Service
Revenue:
Total revenue	1,167.8	1,024.2	916.2
Cost of revenue:
Total cost of revenue	$ 352.8	$ 325.9	$ 287.5

ISRG Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 2,750.1	$ 1,581.2
Short-term investments	2,473.1	2,536.7
Accounts receivable, net of allowances of $27.1 and $22.4 as of December 31, 2023, and 2022, respectively	1,130.2	942.1
Inventory	1,220.6	893.2
Prepaids and other current assets	314.0	299.8
Total current assets	7,888.0	6,253.0
Property, plant, and equipment, net	3,537.6	2,374.2
Long-term investments	2,120.0	2,623.6
Deferred tax assets	910.5	664.6
Intangible and other assets, net	636.7	710.1
Goodwill	348.7	348.5
Total assets	15,441.5	12,974.0
Current liabilities:
Accounts payable	188.7	147.0
Accrued compensation and employee benefits	436.4	401.6
Deferred revenue	446.1	397.3
Other accrued liabilities	587.5	476.2
Total current liabilities	1,658.7	1,422.1
Other long-term liabilities	385.5	439.3
Total liabilities	2,044.2	1,861.4
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of December 31, 2023, and 2022	0.0	0.0
Common stock, 600.0 shares authorized, $0.001 par value, 352.3 shares and 350.0 shares issued and outstanding as of December 31, 2023, and 2022, respectively	0.4	0.4
Additional paid-in capital	8,576.4	7,703.9
Retained earnings	4,743.0	3,500.1
Accumulated other comprehensive loss	(12.2)	(162.5)
Total Intuitive Surgical, Inc. stockholders’ equity	13,307.6	11,041.9
Noncontrolling interest in joint venture	89.7	70.7
Total stockholders’ equity	13,397.3	11,112.6
Total liabilities and stockholders’ equity	$ 15,441.5	$ 12,974.0

About Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

CEO	Dr. Gary S. Guthart Ph.D.
WEBSITE	intuitive.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	12120

Intuitive Surgical Inc Frequently Asked Questions

What is the ticker symbol for Intuitive Surgical Inc? What does ISRG stand for in stocks?

ISRG is the stock ticker symbol of Intuitive Surgical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Intuitive Surgical Inc (ISRG)?

As of Thu Apr 18 2024, market cap of Intuitive Surgical Inc is 131.35 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ISRG stock?

You can check ISRG's fair value in chart for subscribers.

What is the fair value of ISRG stock?

You can check ISRG's fair value in chart for subscribers. The fair value of Intuitive Surgical Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Intuitive Surgical Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ISRG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Intuitive Surgical Inc a good stock to buy?

The fair value guage provides a quick view whether ISRG is over valued or under valued. Whether Intuitive Surgical Inc is cheap or expensive depends on the assumptions which impact Intuitive Surgical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ISRG.

What is Intuitive Surgical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, ISRG's PE ratio (Price to Earnings) is 73.06 and Price to Sales (PS) ratio is 18.44. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ISRG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Intuitive Surgical Inc's stock?

In the past 10 years, Intuitive Surgical Inc has provided 0.234 (multiply by 100 for percentage) rate of return.